Mass screening in Sweden for cancer of the uterine cervix: effect on incidence and mortality. An overview

Gynecologic and Obstetric Investigation
O Kjellgren

Abstract

An overview of mass screening for precancer and invasive cancer of the cervix uteri in Sweden 1964-1980 is given. Results of the screening program are presented. The decrease of incidence and mortality from invasive cancer of the cervix is presented and discussed. The increase of diagnosis of cancer in situ is illustrated.

Citations

Mar 28, 1997·International Journal of Cancer. Journal International Du Cancer·S ForsmoO A Haugen
Aug 17, 1999·International Journal of Cancer. Journal International Du Cancer·P NieminenM Hakama
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Parthasarathi BasuUNKNOWN Calcutta Cervical Neoplasia Early Detection Strudy (CEDS) Group
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Urmi SenMaqsood Siddiqi
Jan 1, 1995·Journal of Cellular Biochemistry. Supplement·C P Morrow, W Cozen
Nov 1, 1995·Cancer Causes & Control : CCC·T BjørgeS O Thoresen
May 9, 2008·International Journal of Clinical Oncology·Donald Maxwell Parkin
Feb 1, 1995·Clinical Biochemistry·A B Miller
Mar 1, 1996·European Journal of Obstetrics, Gynecology, and Reproductive Biology·G Dubois
May 1, 1988·The Journal of Family Practice·C Pederson
Apr 13, 2005·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·J SherrisS Luciani
Oct 11, 2003·Obstetrics and Gynecology·Pamela G ChanGeorge F Sawaya
Jul 31, 1999·Archives of Medical Research·E C Lazcano-PonceM Hernández Avila
May 29, 2002·Archives of Medical Research·Gabriela Torres-MejíaLeobardo Gil-Abadíe
Jul 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·G RoncoR Volante
Jan 1, 1994·International Journal of Technology Assessment in Health Care·A Oshima
Jun 1, 1997·Australian and New Zealand Journal of Public Health·S E ReidH C Britt
Oct 18, 2006·BMC Public Health·Ahti AnttilaPekka Nieminen
Mar 1, 1992·Cancer Causes & Control : CCC·L Gustafsson, H O Adami
Dec 11, 1986·International Journal of Technology Assessment in Health Care·K Ebeling, P Nischan
Apr 16, 1994·Lancet·H O AdamiK J Rothman
Jul 13, 2002·International Journal of Cancer. Journal International Du Cancer·Paul K DrainLaura A Koutsky
Oct 25, 2002·International Journal of Cancer. Journal International Du Cancer·Loraine D MarrettSilvana Luciani
Jul 1, 1997·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·L ElovainioA B Miller
Sep 1, 1991·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W J MelchersW G Quint
Dec 15, 2004·Chest·Peter B BachD Maxwell Parkin
Mar 18, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Matti HakamaAnssi Auvinen
Apr 9, 2005·International Journal of Cancer. Journal International Du Cancer·Rengaswamy SankaranarayananUNKNOWN Osmanabad District Cervical Screening Study Group
Sep 12, 2008·International Journal of Cancer. Journal International Du Cancer·Jae Kwan JunKeun-Young Yoo
Jan 1, 1986·Journal of Chronic Diseases·A B Miller
Jan 1, 1990·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H BrennerH Ziegler
Nov 1, 1990·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·K O RogoU Stendahl
Jan 1, 1989·Journal of Clinical Epidemiology·A C KlassenR Brookmeyer
Jan 1, 1991·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·J M Machoki, K O Rogo
Apr 1, 1990·Gynecologic Oncology·K O Rogo, Kavoo-Linge
Jan 1, 1986·Journal of Chronic Diseases·A J SascoS D Walter
Feb 7, 2004·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·P BoyleP Autier
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T AareleidM Hakama
Sep 20, 2005·Preventive Medicine·Rosella P M G HermensChris van Weel
Oct 1, 1989·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·F Pettersson, B Malker
Jan 1, 1989·Scandinavian Journal of Urology and Nephrology·P CarlssonE Varenhorst
Apr 21, 2007·Orvosi hetilap·Attila KovacsAgnes Cornides

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.